Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Age-related differences in striatal dopamine D1 receptors mediate subjective drug effects
Peter Manza, … , Gene-Jack Wang, Nora D. Volkow
Peter Manza, … , Gene-Jack Wang, Nora D. Volkow
Published November 10, 2022
Citation Information: J Clin Invest. 2023;133(1):e164799. https://doi.org/10.1172/JCI164799.
View: Text | PDF
Research Letter Neuroscience

Age-related differences in striatal dopamine D1 receptors mediate subjective drug effects

  • Text
  • PDF
Abstract

Authors

Peter Manza, Ehsan Shokri-Kojori, Şükrü Barış Demiral, Rui Zhang, Evan Dennis, Allison Johnson, Leah Vines, Diana Sotelo, Dardo Tomasi, Gene-Jack Wang, Nora D. Volkow

×

Figure 1

Associations among markers of brain dopamine system function, age, and subjective drug effects.

Options: View larger image (or click on image) Download as PowerPoint
Associations among markers of brain dopamine system function, age, and s...
(A) Regression plots depicting the association of age and subjective drug effects with striatal dopamine D1-like dopamine receptor (D1R), D2R, and methylphenidate-induced (MP-induced) dopamine increases. All analyses were controlled for BMI and sex. (B) Negative association between subjective drug effects and age. To quantify total effects of the drug across the session, we calculated area under the curve (AUC) for all time points (every 5 minutes, from –5 minutes to 120 minutes after administration of MP) and subtracted the AUC between the MP and placebo (PLA) sessions to get one estimate of the cumulative drug effects per participant. Thus, a negative value for “feel drug effects” indicates a greater subjective response to PLA than MP. (C) A selective role for D1R but not D2R in the subjective effects of MP. Nucleus accumbens D1R but not D2R availability was significantly associated with subjective drug effects. The difference in regression slopes was significant (z = 3.699, P < 0.001). (D) D1R availability in the nucleus accumbens mediates the negative association between age and subjective drug effects. DVR, distribution volume ratio. *P < 0.05; ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts